GVB Biopharma
Las Vegas, US · Founded 2019 · Nevada corporation
GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.
Founders & leadership
GVB Biopharma was founded in 2019 by Drew Spiegel.
DS
Drew SpiegelCEO & Co-Founder
SR
Sebastian RavitzChief Marketing Officer
JM
Joe MaherChief Financial Officer
TS
Theodore SwindellsNamed on SEC filing
PS
Phillip SwindellsCOO & Co-Founder
WS
William SpiegelNamed on SEC filing
JF
Jack FeldmanPresident & Co-Founder
Reported raises · per SEC filings
Form D private placements$13.6M disclosed across 6 rounds · 2020–2022
▶$1MraisedMay 2022 · 1 investors · ManufacturingRule 506(b)
▶$1MraisedMay 2022 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Theodore SwindellsDirector
- William SpiegelExecutive Officer, Director
- Jack FeldmanExecutive Officer, Director
- Phillip SwindellsExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $50K
- Sales commissions
- $100K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- Apr 2022
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
▶$1.8MraisedJan 2022 · 2 investors · ManufacturingRule 506(b)
▶$1.8MraisedJan 2022 · 2 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- William SpiegelExecutive Officer, Director
- Theodore SwindellsDirector
- Phillip SwindellsExecutive Officer, Director
- Jack FeldmanExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- Minimum investment
- $50K
- Sales commissions
- $25K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- Jan 2022
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
▶$1.5MraisedNov 2021 · 10 investors · ManufacturingRule 506(b)
▶$1.5MraisedNov 2021 · 10 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- William SpiegelExecutive Officer, Director
- Phillip SwindellsExecutive Officer, Director
- Theodore SwindellsDirector
- Jack FeldmanExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- Sales commissions
- $100K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- Oct 2021
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
▶$7.6MraisedNov 2020 · 28 investors · ManufacturingRule 506(b)
▶$7.6MraisedNov 2020 · 28 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Theodore SwindellsDirector
- William SpiegelExecutive Officer, Director
- Jack FeldmanExecutive Officer, Director
- Phillip SwindellsExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7.6M
- Minimum investment
- $500K
- Sales commissions
- $640K
- Placement agents
- M.S. Howells & Co., TerraNova Capital Equities, Inc.
- First sale
- Nov 2020
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
▶$1.3MraisedMay 2020 · 1 investors · ManufacturingRule 506(b)
▶$1.3MraisedMay 2020 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- William SpiegelExecutive Officer, Director
- Jack FeldmanExecutive Officer, Director
- Phillip SwindellsExecutive Officer, Director
- Theodore SwindellsDirector
- Offering amount
- $3M
- Amount sold
- $1.3M
- Minimum investment
- $50K
- Sales commissions
- $300K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- May 2020
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
▶$450KraisedApr 2020 · 4 investors · ManufacturingRule 506(b)
▶$450KraisedApr 2020 · 4 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Theodore SwindellsDirector
- Phillip SwindellsExecutive Officer, Director
- William SpiegelExecutive Officer, Director
- Jack FeldmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $450K
- Minimum investment
- $50K
- Sales commissions
- $200K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- Feb 2020
- Incorporated
- Corporation, Nevada, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Leafwell513 shared keywordsLeafwell operates an online telehealth platform that connects patients with doctors to obtain medical marijuana cards. It also publishes evidence-based articles and research on cannabis for patients seeking medical use.
Leafly499 shared keywordsLeafly is an online cannabis marketplace and information resource where consumers can browse strains, brands, deals, and reviews, and place orders with local dispensaries for pickup or delivery. It also publishes articles and strain data for cannabis consumers across legal markets.
Companies competing with GVB Biopharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does GVB Biopharma do?
- GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.
- Who founded GVB Biopharma?
- GVB Biopharma was founded by Drew Spiegel in 2019.
- How much funding has GVB Biopharma raised?
- GVB Biopharma has disclosed $13.6M raised across 6 rounds.
- Where is GVB Biopharma headquartered?
- GVB Biopharma is headquartered in Las Vegas, US.